Abstract
We recently developed a user-friendly web-based application called bc-GenExMiner (http://bcgenex.centregauducheau.fr), which offered the possibility to evaluate prognostic informativity of genes in breast cancer by means of a 'prognostic module'. In this study, we develop a new module called 'correlation module', which includes three kinds of gene expression correlation analyses. The first one computes correlation coefficient between 2 or more (up to 10) chosen genes. The second one produces two lists of genes that are most correlated (positively and negatively) to a 'tested' gene. A gene ontology (GO) mining function is also proposed to explore GO 'biological process', 'molecular function' and 'cellular component' terms enrichment for the output lists of most correlated genes. The third one explores gene expression correlation between the 15 telomeric and 15 centromeric genes surrounding a 'tested' gene. These correlation analyses can be performed in different groups of patients: all patients (without any subtyping), in molecular subtypes (basal-like, HER2+, luminal A and luminal B) and according to oestrogen receptor status. Validation tests based on published data showed that these automatized analyses lead to results consistent with studies' conclusions. In brief, this new module has been developed to help basic researchers explore molecular mechanisms of breast cancer. DATABASE URL: http://bcgenex.centregauducheau.fr
MeSH Terms
Breast Neoplasms/classification,genetics
Chromosomes, Human/genetics
Computational Biology/methods
Data Mining
Female
Gene Expression Regulation, Neoplastic
Genes, Neoplasm/genetics
Humans
Molecular Sequence Annotation
Multigene Family/genetics
Neoplasm Proteins/metabolism
Receptors, Estrogen/genetics,metabolism
Reproducibility of Results
Software
Statistics as Topic
Chemicals
Neoplasm Proteins
Receptors, Estrogen
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Jézéquel Pascal
Unité Mixte de Génomique du Cancer, Hôpital Laënnec/Institut de Cancérologie de l'Ouest - site René Gauducheau, Bd J. Monod, 44805 Nantes - Saint Herblain Cedex, France. pascal.jezequel@ico.unicancer.fr
Frénel Jean-Sébastien
Campion Loïc
Guérin-Charbonnel Catherine
Gouraud Wilfried
Ricolleau Gabriel
Campone Mario
References (23)
23 references, click to expand
-
Impact of DNA amplification on gene expression patterns in breast cancer.
Cancer Res. 2002 Nov 1;62(21):6240-5
PMID: 12414653
-
bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer.
Breast Cancer Res Treat. 2012 Feb;131(3):765-75
PMID: 21452023
-
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
Genes Chromosomes Cancer. 2006 Nov;45(11):1033-40
PMID: 16897746
-
A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Breast Cancer Res Treat. 2009 Aug;116(3):509-20
PMID: 19020972
-
Identification of aberrant chromosomal regions from gene expression microarray studies applied to human breast cancer.
Bioinformatics. 2007 Sep 1;23(17):2273-80
PMID: 17599933
-
About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer.
Mol Cell Endocrinol. 2004 Apr 30;219(1-2):1-7
PMID: 15149721
-
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.
Breast Cancer Res. 2008;10(4):R65
PMID: 18662380
-
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
Br J Cancer. 2009 Jul 7;101(1):166-73
PMID: 19513072
-
Complex sense-antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progression.
BMC Genomics. 2010 Feb 10;11 Suppl 1:S9
PMID: 20158880
-
Genetic alterations and oncogenic pathways associated with breast cancer subtypes.
Mol Cancer Res. 2009 Apr;7(4):511-22
PMID: 19372580
-
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.
Nat Genet. 2000 May;25(1):25-9
PMID: 10802651
-
Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes.
Cancer Res. 2004 Dec 1;64(23):8541-9
PMID: 15574760
-
ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1.
PLoS Genet. 2011 Apr;7(4):e1001382
PMID: 21552322
-
Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy.
Br J Cancer. 2007 Jan 29;96(2):341-51
PMID: 17133270
-
Genomic distance entrained clustering and regression modelling highlights interacting genomic regions contributing to proliferation in breast cancer.
BMC Syst Biol. 2010 Sep 08;4:127
PMID: 20825665
-
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12963-8
PMID: 12297621
-
Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
Clin Cancer Res. 2009 Jan 15;15(2):441-51
PMID: 19147748
-
Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
Clin Cancer Res. 2010 Jan 15;16(2):651-63
PMID: 20068109
-
Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study.
Int J Cancer. 2012 Jul 15;131(2):426-37
PMID: 21898387
-
DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
Genes Chromosomes Cancer. 2008 Jun;47(6):490-9
PMID: 18314908
-
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
Cancer Cell. 2006 Dec;10(6):529-41
PMID: 17157792
-
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.
Cancer Res. 2008 Sep 1;68(17):7165-75
PMID: 18757432
-
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
J Clin Invest. 2011 Jul;121(7):2750-67
PMID: 21633166